Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its tissue of origin from a single blood sample.
Godavari Biorefineries shares rises 10% on Japanese patent for cancer treatment invention
Godavari Biorefineries said the patented invention relates to the use of 5-Hydroxy-1,4-Naphthalenedione in the treatment of cancer and strengthens its intellectual property portfolio in the healthcare and life sciences space.
Analysts project up to 17% upside in healthcare stocks trading at new highs
Apollo Hospitals, Aster DM Healthcare, Sai Life Sciences have rallied up to 27% thus far in FY27; technical analysts remain bullish on these stocks given the favourable chart set-up.
Jagran Prakashan Ltd leads losers in 'B' group
Suven Life Sciences Ltd, Ravindra Energy Ltd, Sunflag Iron & Steel Company Ltd and Exicom Tele-Systems Ltd are among the other losers in the BSE's 'B' group today, 05 June 2026.
Sai Life, Laurus Labs hit new highs; stocks rally up to 40% in 6 months
Sai's management reiterated long-term guidance of 15-20 per cent revenue CAGR with 28-30 per cent steady state EBITDA margin over the next two to three years.
Sunil Singhania’s Abakkus Portfolio: 6 stocks rally up to 75% in CY26; 5 new buys added in Q4
Sunil Singhania’s Abakkus Asset Manager portfolio rose 6% to Rs 2,742 crore in March 2026 quarter, with mixed CY26 performance showing strong gains in Avalon Technologies and Suven Life Sciences amid several notable stock declines.
Fractal Analytics Q4 Results: Profit more than doubles to Rs 116 crore
Fractal Analytics reported a significant financial leap, with its Q4 profit after tax doubling to Rs 116 crore, fueled by an impressive 82% surge in its healthcare and life sciences division. The company's overall revenue also saw a healthy 17% increase. This robust performance, coupled with a debt-free status post-IPO, positions Fractal for continued expansion.
Laurus, Sai Life Sciences up 3% in weak market; what's driving CDMO stocks?
In the past one month, Laurus (up 14 per cent) and Sai Life (up 15 per cent) have outperformed the market by soaring up to 15 per cent
Stock market today: Gift Nifty signals gap-up start; election results, India VIX to Q4 results — 7 stocks to buy or sell
Stock market today: Experts recommend these eight stocks to buy today —Sona Blw Precision Forgings, Sai Life Sciences, Reliance, SAIL, GPPL, Thermax, and Tata Capital
Bombay HC backs GSK in Paxil trademark row against Shreya Life Sciences
The Indian subsidiary of the UK-based GSK PLC had urged the court to cancel the mark used by the local company in pharmaceutical and medicinal preparations. It argued that despite getting the mark more than two decades ago, Shreya Life Sciences had never used it and hence, under Section 47 of the Trade Marks Act, the registration was liable to be removed from the register of trade marks on account of non-use.
RPG Life Sciences Q4 Results: Operating performance strong, base quarter one-off impacts profit
Shares of RPG Life Sciences Ltd ended at ₹2,024.05, down by ₹34.70, or 1.69%, on the BSE.